Activatable near-infrared probes for the detection of specific populations of tumour-infiltrating leukocytes in vivo and in urine
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunotherapy using checkpoint blockade
Ribas, A., & Wolchok, J. D. (2018) · Science · doi:10.1126/science.aar4060 · Cited by 6,791
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893 · cited 1×
“Cancer immunotherapy has revolutionized the landscape of oncology 1 .”
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263 · cited 1×
“In particular, clinical data have revealed that high levels of M1 macrophages and cytotoxic T lymphocytes (CTLs) are associated with a positive prognosis 4 , whereas an increased neutrophil– lymphocyte ratio predicted poor survival of the patients with cancer 5 .”
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712 · cited 1×
“…is known to inhibit cancer growth by inducing immunogenic cell death (ICD) for activating dendritic cells (DCs) and improving T-cell infiltration 35 . aPD-L1 was used to inhibit the binding of programmed death-ligand 1 (PD-L1) to programmed cell death protein 1 (PD-1) receptor expressed on T…”
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Awad, F., Assrawi, E., Jumeau, C., Georgin-Lavialle, S., Cobret, L., Duquesnoy, P., Piterboth, W., Thomas, L., Stankovic-Stojanovic, K., Louvrier, C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175336 · Cited by 191 · cited 3×
“23–25); besides, the double-positive cells defined by those labelled with both TAMPs and antibody accounted for ~55% of the respective TILs (Fig.”
AND-gate contrast agents for enhanced fluorescence-guided surgery
Widen, J. C., Tholen, M., Yim, J. J., Antaris, A., Casey, K. M., Rogalla, S., Klaassen, A., Sorger, J., & Bogyo, M. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00616-6 · Cited by 142
Cited by
Liu, Y., Zhang, Z., Hou, X., Ding, Q., Zeng, S., Shen, H., Gong, W., Ding, T., Mahmood, Z., Zeng, X., et al. (2025) · Advanced Materials · doi:10.1002/adma.202420006 · Cited by 30
Metadata
- Authors
- He, S., Cheng, P., & Pu, K.
- Venue
- Nature Biomedical Engineering
- Published
- 2023-03-20
- Volume
- 7
- Issue
- 3
- Pages
- 281-297
- ISSN
- 2157-846X (ISSN-L)
- OpenAlex
- W4328049508
- Cited by
- 172
- References
- 8
- FWCI
- 15.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activatable near-infrared probes for the detection of specific populations of tumour-infiltrating leukocytes in vivo and in urine. https://app.cochat.ai/papers/10.1038/s41551-023-01009-1
- The paper
- He, S., Cheng, P., & Pu, K. (2023). Activatable near-infrared probes for the detection of specific populations of tumour-infiltrating leukocytes in vivo and in urine. Nature Biomedical Engineering. https://doi.org/10.1038/s41551-023-01009-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.